Correlation Between Neurocrine Biosciences and Phibro Animal

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Phibro Animal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Phibro Animal into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Phibro Animal Health, you can compare the effects of market volatilities on Neurocrine Biosciences and Phibro Animal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Phibro Animal. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Phibro Animal.

Diversification Opportunities for Neurocrine Biosciences and Phibro Animal

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neurocrine and Phibro is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Phibro Animal Health in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Phibro Animal Health and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Phibro Animal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Phibro Animal Health has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Phibro Animal go up and down completely randomly.

Pair Corralation between Neurocrine Biosciences and Phibro Animal

Given the investment horizon of 90 days Neurocrine Biosciences is expected to generate 0.54 times more return on investment than Phibro Animal. However, Neurocrine Biosciences is 1.85 times less risky than Phibro Animal. It trades about 0.41 of its potential returns per unit of risk. Phibro Animal Health is currently generating about 0.13 per unit of risk. If you would invest  13,786  in Neurocrine Biosciences on November 3, 2024 and sell it today you would earn a total of  1,396  from holding Neurocrine Biosciences or generate 10.13% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Neurocrine Biosciences  vs.  Phibro Animal Health

 Performance 
       Timeline  
Neurocrine Biosciences 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.
Phibro Animal Health 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Phibro Animal Health has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical indicators, Phibro Animal is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Neurocrine Biosciences and Phibro Animal Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neurocrine Biosciences and Phibro Animal

The main advantage of trading using opposite Neurocrine Biosciences and Phibro Animal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Phibro Animal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Phibro Animal will offset losses from the drop in Phibro Animal's long position.
The idea behind Neurocrine Biosciences and Phibro Animal Health pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets